Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jul;52(8):2752-2753.
doi: 10.1007/s00259-025-07136-y.

The promising potential of camelid nanobodies for nuclear medicine

Hans J Biersack  1   2 , Alejandro Rojas-Fernandez  3 , Hong-Hoi Ting  4 , Vasko Kramer  5 , Malik E Juweid  6 , Felix M Mottaghy  7   8
Affiliations
Editorial

The promising potential of camelid nanobodies for nuclear medicine

Hans J Biersack et al. Eur J Nucl Med Mol Imaging. 2025 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: Hans-Jürgen Biersack is medical advisor for NanoMab Technology Ltd. Alejandro Rojas-Fernandez is employer of Berking Theranostics Hamburg, Germany. Hong-Hoi Ting is employer of NanoMab Technology Ltd, chief strategic officer of Full-Life technologies and scientific advisory board member of Radiopharm theranostics. Vasko Kramer is employer of Acrux Radiopharma Consulting SpA. Malik Juweid has nothing to declare.Felix M. Mottaghy is medical advisor for NanoMab Technology Ltd. and Advanced Accelerator Applications (AAA) GmbH/Novartis and has recently received institutional grants from NanoMab Technology Ltd., Siemens, and GE Precision HealthCare LLC. He is also supported by the German Research Foundation (DFG) within the framework of the Research Training Group 2375 “Tumor-targeted Drug Delivery” (grant 331065168), the Clinical Research Unit CRU 5011 “Integrating emerging methods to advance translational kidney research (InteraKD)” (project 445703531). In addition, his research is funded by the German Federal Ministry of Research and Education (project 16GW0319K). Moreover, he is an associate editor of the European Journal of Nuclear Medicine and Molecular Imaging.

References

    1. Hochhaus A, Schlag PM, Cordes N, Höffken K. Paul Ehrlichs “magic bullets”. Der Onkologe. 2013;19:806–8.
    1. Biersack HJ, Bockisch A, Oehr P, et al. Clinical results of immunoscintigraphy in a variety of malignant tumors with special reference to immunohistochemistry. Nuklearmedizin. 1986;25:167–71. - PubMed
    1. Hamers-Casterman C, Atarhouch T, Muyldermans S, et al. Naturally occurring antibodies devoid of light chains. Nature. 1993;363:446–8. - PubMed
    1. Bao G, Tang M, Zhao J, et al. Nanobody: a promising toolkit for molecular imaging and disease therapy. EJNMMI Res. 2021;11:6. 10.1186/s13550-021-00750-5. - PMC - PubMed
    1. Wong NC, Cai Y, Meszaros LK, et al. Preclinical development and characterisation of (99m)Tc-NM-01 for SPECT/CT imaging of human PD-L1. Am J Nucl Med Mol Imaging. 2021;11:154–66. - PMC - PubMed

Publication types

LinkOut - more resources